Genetic tests may cut insulin need

Primary care genetics society Genetics and diabetes type, response to statins and bowel disease.

Treatment of maturity onset diabetes of the young (MODY) can be significantly improved by knowing its genetic basis and some patients can even be taken off insulin.

Mark Walker, professor of molecular diabetic medicine at Newcastle University, urged GPs at the Primary Care Genetics Society conference in Newcastle last week to refer their MODY patients for genetic testing.

Distinguishing between MODY2 and MODY3, the most common types, can allow some patients to stay off therapy while protecting others by using early sulphonylurea treatment.

The gene mutations causing common forms of MODY are highly penetrant, Professor Walker said.

'The genetic heterogeneity contributes to the clinical heterogeneity and identifying the responsible gene can influence clinical management,' he said.

Patients with MODY3, the commonest form of MODY, caused by a mutation in the hepatocyte nuclear factor-1-alpha gene on chromosome 12, see rapid progression of their diabetes to insulin-dependency and have a high rate of small vessel complications. But they are hypersensitive to sulphonylureas and can react to a standard starting dose of 80mg gliclazide with hypoglycaemia.

'If a young person who is newly diagnosed, with a strong family history, does not give a full dose of sulphonylureas, assume it could be MODY,' Professor Walker said.

Fasting glucose levels are high and young people are started on insulin but can be treated with sulphonylureas, he said.

Mutations in the glucokinase gene on chromosome seven cause MODY2 in 95 per cent of patients by the age of 40 but rapid progression of the diabetes and small vessel complications are rare.

'This is a stable condition with a low risk of complications,' he said. MODY accounts for 1-3 per cent of type-2 diabetes and GPs typically have one or two patients.

Professor Walker urged referral of diabetics under 40 without ketones at diagnosis who show a strong family history and sensorineural deafness, as they might have mitochondrial diabetes.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Dr Zoe Norris

GPDF slashes costs and overhauls funding rules to 'restore trust' with GPs

The General Practice Defence Fund (GPDF) has cancelled contracts worth hundreds of...

Churchill Gardens

Scheme from Brazil helps address health inequalities in London practice

A scheme involving community health and wellbeing workers, which is based on a long-standing...

Talking General Practice logo

Podcast: How an initiative from Brazil could help general practice and improve outcomes

Dr Matt Harris and London GP Dr Connie Junghans Minton explain how an initiative...

Medical centre sign

One in three GP practices in Northern Ireland faced serious closure risk in past 18 months

One in three GP practices in Northern Ireland have faced a serious risk of closure...

BMA sign

BMA warns Treasury 'many practices' will close without emergency financial support

GP leaders have urged the Treasury to agree emergency funding to support general...


Practices can use £172m PCN cash to support staff pay rises, GP leaders say

Practices can use their share of Β£172m from the 2023/24 investment and impact fund...